BioClin Therapeutics

BioClin Therapeutics is a clinical stage drug development company developing biologics to address high unmet medical needs. Our lead product candidate, B-701, a first-in-class human monoclonal antibody targeting FGFR3 (fibroblast growth factor receptor 3) for the treatment of metastatic bladder cancer.
 
 
BioClin Therapeutics
 

Details
BioClin Therapeutics
130 Market Place, PMB 295
San Ramon, California 94583
USA
www.bioclintherapeutics.com